Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEURON: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neurons are the fundamental information-processing cells of the nervous system, transmitting electrical and chemical signals across synapses. The human brain contains approximately 86 billion neurons organized into circuits for perception, cognition, and motor control. Key subtypes include excitatory glutamatergic pyramidal neurons, inhibitory GABAergic interneurons (parvalbumin+, somatostatin+, VIP+), dopaminergic neurons (substantia nigra, VTA), and cholinergic neurons (basal forebrain). Selective neuronal vulnerability is a hallmark of neurodegeneration: entorhinal cortex layer II neurons in AD, dopaminergic neurons in PD, motor neurons in ALS, and medium spiny neurons in HD. Neuronal loss correlates more strongly with cognitive decline than amyloid plaques, driving interest in neuroprotective strategies.
No AI portrait yet
| Gene Symbol | NEURON |
| Protein Type | Enzyme |
| Function | Alternative splicing regulation |
| Primary Expression | neuroendocrine cells) | |
| Molecular Weight | 45 kDa |
| Amino Acids | 433 aa |
| Pathways | NEURODEGENERATION, NEUROINFLAMMATION |
| GeneCards | NEURON |
| Human Protein Atlas | NEURON |
| Role | Complements TIA-1 in SG formation |
| Domain structure | Multiple RNA-binding domains, IDR |
| Phosphorylation | Regulates SG formation |
| Disease mutations | ALS-associated G3BP1/2 mutations affect SG dynamics |
| Alternative splicing | TIA-1 and TIA1R variants |
| Pathology | TIA-1 positive inclusions in ALS/FTD |
| Associated Diseases | Aging, Als, Alzheimer, ALZHEIMER'S DISEASE, Amyotrophic Lateral Sclerosis |
| Known Drugs/Compounds | APIGENIN, DESCHLOROCLOZAPINE, DONEPEZIL, EDARAVONE, FINGOLIMOD, LEVODOPA |
| Interactions | 6-OHDA, AADC, ABCA1, ACAT1, ACHE, ACTB |
| KG Connections | 5389 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
NEURON["NEURON"] -->|"associated with"| Parkinson["Parkinson"]
NEURON["NEURON"] -->|"causes"| Neurodegeneration["Neurodegeneration"]
AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| NEURON["NEURON"]
NEUROINFLAMMATION_2["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| NEURON["NEURON"]
MICROGLIA_3["MICROGLIA"] -->|"associated with"| NEURON["NEURON"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| NEURON["NEURON"]
ALS["ALS"] -->|"associated with"| NEURON["NEURON"]
end
subgraph Signaling["Signaling"]
NEURON["NEURON"] -->|"activates"| MICROGLIA["MICROGLIA"]
NEURON["NEURON"] -->|"activates"| Neurodegeneration_1["Neurodegeneration"]
NEURON["NEURON"] -->|"activates"| Alzheimer["Alzheimer"]
NEURON["NEURON"] -->|"activates"| Dementia["Dementia"]
NEURON["NEURON"] -->|"activates"| Mtor["Mtor"]
NEURON["NEURON"] -->|"activates"| Aging["Aging"]
NEURON["NEURON"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
end
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style Parkinson fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neurodegeneration_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Dementia fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Aging fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEUROINFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEUROINFLAMMATION_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA_3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURODEGENERATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | associated_with | disease | 1.00 |
| Stem Cell | activates | pathway | 1.00 |
| Als | inhibits | disease | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Dementia | associated_with | disease | 1.00 |
| Dementia | activates | disease | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Mtor | activates | pathway | 1.00 |
| Neurodegeneration | causes | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 1.00 |
| Dementia | causes | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Aging | inhibits | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Parkinson | activates | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Als | expressed_in | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Als | regulates | disease | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| Mitophagy | activates | pathway | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| MTOR | activates | gene | 1.00 |
| Complement | activates | pathway | 1.00 |
| Inflammation | associated_with | disease | 0.95 |
| Parkinson | causes | disease | 0.95 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.95 |
| Alzheimer | regulates | disease | 0.95 |
| Neurodegeneration | regulates | disease | 0.95 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.95 |
| STEM CELLS | activates | cell_type | 0.95 |
| SYNAPTIC PLASTICITY | activates | process | 0.95 |
| TDP-43 | interacts_with | gene | 0.95 |
| OLIGODENDROCYTES | activates | cell_type | 0.95 |
| OLIGODENDROCYTES | regulates | cell_type | 0.95 |
| Stroke | activates | disease | 0.95 |
| HCRTR2 | interacts_with | protein | 0.90 |
| HCRTR1 | interacts_with | protein | 0.90 |
| SNCA | associated_with | gene | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON | activates | gene | 1.00 |
| APOPTOSIS | associated_with | gene | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| ASTROCYTE | activates | cell_type | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| MICROGLIA | associated_with | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| optogenetic stimulation | targets | process | 1.00 |
| TARDBP | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| SOD1 | associated_with | gene | 1.00 |
| NF-KB | associated_with | protein | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| NF-ΚB | activates | gene | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| ALS | activates | gene | 1.00 |
| ASTROCYTES | associated_with | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| ALS | associated_with | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| GENES | expressed_in | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 1.00 |
| MOTOR NEURONS | associated_with | gene | 1.00 |
| ROS | activates | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 1.00 |
| MICROGLIA ACTIVATION | activates | gene | 1.00 |
| COMPLEMENT | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 0.98 |
| MICROGLIA | inhibits | cell_type | 0.98 |
| APP | associated_with | gene | 0.98 |
| NEUROINFLAMMATION | activates | gene | 0.98 |
| NEUROFIBRILLARY TANGLES | interacts_with | protein | 0.95 |
| ENDOTHELIAL CELLS | interacts_with | cell_type | 0.95 |
| NEUROGENESIS | activates | process | 0.95 |
| Autophagy | expressed_in | pathway | 0.95 |
| GSDME | expressed_in | protein | 0.95 |
| NEUROGENESIS | associated_with | process | 0.95 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plant-based dietary patterns and Alzheimer's disease risk in multiethn | clinical | Alzheimer's disease and relate | 0.950 | 0.00 | human patients | proposed | N/A |
| SIRPα modulation in mouse models of Alzheimer's disease | validation | Alzheimer's disease | 0.900 | 0.00 | mouse models of Alzheimer's di | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning NEURON in their description or question text
Score: 0.900 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and bloc
Score: 0.896 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant
Score: 0.867 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau
Score: 0.863 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activatio
Score: 0.863 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling a
Score: 0.858 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct
Score: 0.857 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat
Score: 0.846 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening to restore hippo
Score: 0.845 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activati
Score: 0.843 · molecular neurobiology · 2026-04-17
## Mechanistic Overview Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Spe
Score: 0.831 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and bl
Score: 0.827 · Alzheimer's disease · 2026-04-16
## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph
Score: 0.827 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to resto
Score: 0.827 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance
Score: 0.812 · neurodegeneration · 2026-04-17
## Mechanistic Overview SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent Neuronal and Endo